Bedside heparin monitoring by activated partial thromboplastin time measured with a dry reagent

被引：0

作者：

Linder, R ^{[1
]}

Grip, L ^{[1
]}

Olason, E ^{[1
]}

Blomback, M ^{[1
]}

机构：

[1] KAROLINSKA HOSP, DEPT LAB MED BLOOD COAG RES, S-17176 STOCKHOLM, SWEDEN

来源：

CLINICAL CHEMISTRY | 1996年 / 42卷 / 09期

关键词：

D O I：

暂无

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：1488 / 1489

页数：2

共 50 条

[41] USE OF ACTIVATED PARTIAL THROMBOPLASTIN TIME IN CONTROL OF HEPARIN ADMINISTRATION
LENAHAN, JG
FRYE, S
PHILLIPS, GE
[J]. CLINICAL CHEMISTRY, 1966, 12 (05) : 263 - &
[42] Preparation of lyophilized partial thromboplastin time reagent composed of synthetic phospholipids: Usefulness for monitoring heparin therapy
vandenBesselaar, AMHP
Neuteboom, J
MeeuwisseBraun, J
Bertina, RM
[J]. CLINICAL CHEMISTRY, 1997, 43 (07) : 1215 - 1222
[43] CONTROL OF HEPARIN-THERAPY WITH AN ACTIVATED PARTIAL THROMBOPLASTIN TIME
AKKERMAN, JW
BOUMA, BN
SIXMA, JJ
[J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1972, 29 : 416 - &
[44] MEASUREMENT OF HEPARIN POTENCY WITH AN ACTIVATED PARTIAL THROMBOPLASTIN TIME PROCEDURE
MEYERS, SG
KRAMER, D
[J]. PHARMACOPEIAL FORUM, 1993, 19 (06): : 6621 - 6625
[45] Heparin overdoseIncreased activated partial thromboplastin time: case report
[J]. Reactions Weekly, 2016, 1599 (1) : 113 - 113
[46] Evaluation of the activated clotting time and activated partial thromboplastin time for the monitoring of heparin in adult extracorporeal membrane oxygenation patients
Atallah, S.
Liebl, M.
Fitousis, K.
Bostan, F.
Masud, F.
[J]. PERFUSION-UK, 2014, 29 (05): : 456 - 461
[47] IN-VITRO EFFECT OF HEPARIN ON ACTIVATED PARTIAL THROMBOPLASTIN TIME
SOLOWAY, HB
BELLIVEAU, RR
BUTLER, TJ
GRAYSON, JW
[J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1972, 58 (04) : 405 - +
[48] Substitution of a heparin correlation value for activated partial thromboplastin time in heparin nomograms
Miller, Abigail E.
Montague, Deborah
Rodgers, Jo E.
Sanghvi, Sonali
Whinna, Herbert C.
Krumnacher, Heather
[J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (10) : 893 - 898
[49] USE OF THE ACTIVATED PARTIAL THROMBOPLASTIN TIME FOR MONITORING HEPARIN-THERAPY - PROBLEMS AND POSSIBLE SOLUTIONS
POLLER, L
THOMSON, JM
TABERNER, DA
[J]. RESEARCH IN CLINIC AND LABORATORY, 1989, 19 (04): : 363 - 370
[50] ANTI-FACTOR XA VERSUS ACTIVATED PARTIAL THROMBOPLASTIN TIME FOR HEPARIN INFUSION MONITORING
Jung, Sul
Choi, Austin
Lepore, Mark
[J]. CRITICAL CARE MEDICINE, 2020, 48

← 1 2 3 4 5 →